| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |